![](/img/cover-not-exists.png)
PRO51 COST-EFFECTIVENESS AND BUDGET IMPACT OF ONASEMNOGENE ABEPARVOVEC FOR SPINAL MUSCULAR ATROPHY TYPE 1: POST-HOC ANALYSIS OF A MODEL DEVELOPED BY ICER
Dabbous, O., Dean, R., Arjunji, R., Sproule, D.M., Feltner, D.E., Malone, D.C.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2381
Date:
November, 2019
File:
PDF, 323 KB
2019